These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31972562)

  • 21. Central precocious puberty in a girl with Williams syndrome: the result of treatment with GnRH analogue.
    Utine GE; Alikasifoglu A; Alikasifoglu M; Tuncbilek E
    Eur J Med Genet; 2006; 49(1):79-82. PubMed ID: 16473313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudotumour Cerebri Presentation in a Child Under the Gonadotropin-Releasing Hormone Agonist Treatment.
    Gül Ü; Kaçar Bayram A; Kendirci M; Hatipoğlu N; Okdemir D; Gümüş H; Kurtoğlu S
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):365-7. PubMed ID: 27087351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of central precocious puberty treatment with GnRH analogue at the Triangulo Mineiro Federal University (UFTM).
    Borges Mde F; Franciscon Pde M; Cambraia TC; Oliveira DM; Ferreira BP; Resende EA; Palhares HM
    Arch Endocrinol Metab; 2015 Dec; 59(6):515-22. PubMed ID: 26421668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaphylaxis to gonadorelin acetate in a girl with central precocious puberty.
    Akın O; Yavuz ST; Hacıhamdioğlu B; Sarı E; Gürsel O; Yeşilkaya E
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1387-9. PubMed ID: 26197466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty.
    Albano MC; Latronico AC; Arnhold IJ; Domenice S; Bloise W; Mendonca BB
    J Pediatr Endocrinol Metab; 1997; 10(5):499-503. PubMed ID: 9401906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment?
    Kunz GJ; Sherman TI; Klein KO
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1189-98. PubMed ID: 18183790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
    Kappy M; Stuart T; Perelman A; Clemons R
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High diagnostic accuracy of subcutaneous Triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls.
    Freire AV; Escobar ME; Gryngarten MG; Arcari AJ; Ballerini MG; Bergadá I; Ropelato MG
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):398-404. PubMed ID: 22845185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty.
    Brauner R; Malandry F; Rappaport R
    Eur J Pediatr; 1992 Oct; 151(10):728-30. PubMed ID: 1425790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.
    Weissman A; Barash A; Shapiro H; Casper RF
    Hum Reprod; 1998 Dec; 13(12):3421-4. PubMed ID: 9886527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty.
    Galip N; Ankay N; Bundak R
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):307-311. PubMed ID: 34763385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty.
    Saggese G; Bertelloni S; Baroncelli GI; Battini R; Franchi G
    Eur J Pediatr; 1993 Sep; 152(9):717-20. PubMed ID: 8223799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment.
    Salerno M; Di Maio S; Gasparini N; Mariano A; Macchia V; Tenore A
    Horm Res; 1998; 50(4):205-11. PubMed ID: 9838241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
    Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate.
    Zenaty D; Blumberg J; Liyanage N; Jacqz-Aigrain E; Lahlou N; Carel JC;
    Horm Res Paediatr; 2016; 86(3):188-195. PubMed ID: 27603324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological effects of gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty.
    Yu R; Yang S; Hwang IT
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1071-1075. PubMed ID: 31415238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.